Incredible Growth Of Medical Cannabis Market 2026 Growing With Major Eminent Key Players

Medical Cannabis Market GLOBAL INDUSTRY INSIGHTS, TRENDS, OUTLOOK,
AND OPPORTUNITY ANALYSIS, 2018-2026
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Medical Cannabis Market – Overview
According to the U.S., marijuana was the most widely used drug globally in 2014 with around 183 million users. Such a large user base
makes it highly lucrative taxable opportunity, which is influencing various governments worldwide to initiate studies regarding
legalization of the drug for medicinal use. The National Institute on Drug Abuse is conducting research on cannabis (marijuana) to treat
numerous diseases and conditions such as autoimmune disease, pain, inflammation, seizures, mental disorders, and substance abuse
disorders. Regulatory compliance is a key factor that influences cost, quality, and safety of cannabis (marijuana) medicines, as well as the
capacity for the manufacturers in the medical cannabis market to be responsive, scalable, and innovative.
According to the Medical Marijuana, Inc., an estimated size of the legal marijuana industry in the U.S. was US$ 7.1 billion in 2016 with
increase of 25% Y-o-Y. In 2016, 28 states in the U.S. have legalized marijuana for medicinal purpose with some more gearing up for
votes on the recreational use of marijuana. California, Nevada, Maine, and Massachusetts states in November 2016, voted to legalize the
recreational use of marijuana. The accelerated pace of legalization of cannabis (marijuana) in the U.S. has attracted the attention of global
investors in the medical cannabis market. However, lack of formulation of a comprehensive law pertaining to medical marijuana in some
states inhibits patient access to the drug.
Legalization of medicinal cannabis in various economies is expected to drive the market growth
Some of the major factors driving growth of the market include increasing approval of medicinal cannabis products and increasing
research and development activities. For instance, in March 2017, a law that allows the use of cannabis plant was signed by the German
parliament. This would in turn allow the healthcare professionals to prescribe medicinal cannabis products to the patients suffering from
severe health issues such as chronic pain, vomiting, and nausea
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Medical Cannabis Market Taxonomy:
By Point of Sale:
●
Dispensaries
●
Online Pharmacy
●
Hospital Pharmacy
By Active Ingredient:
●
Tetrahydrocannabinol (THC)
●
Cannabidiol (CBD)
By Therapeutic Application:
●
Pain
●
Arthritis
Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/40
© Coherent market Insights. All Rights Reserved
REPORT DESCRIPTION
Medical Cannabis Market: Key Players
●
BOL Pharma*
●
Tilray.
●
Medreleaf Corporation.
●
Aurora Cannabis, Inc.
●
Canopy Growth Corporation.
●
Insys Therapeutics, Inc.
●
Aphria, Inc.
●
MGC Pharmaceuticals Limited.
●
GW Pharmaceuticals, plc
●
Medical Marijuana Inc.
View this report @
https://www.coherentmarketinsights.com/market-insight/medicinal-cannabis-market-40
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
ABOUT US
Coherent Market Insights is a global market intelligence and consulting organization
focused on assisting its plethora of clients achieve transformational growth by helping
them make critical business decisions. We are headquartered in India, with an office at
the global financial capital in the U.S. Our client base includes players from across all
business verticals in over 150 countries worldwide. We are uniquely positioned to help
businesses around the globe deliver practical and lasting results through various
recommendations about operational improvements, technologies, emerging market
trends and new working methods. We offer both customized and syndicated market
research reports that help our clients create visionary growth plans to provide traction to
their business. We meticulously study emerging trends across various industries at both
the global and regional levels to identify new opportunities for our clientele.
SERVICES
INDUSTRY ANALYSIS
CUSTOMIZED
RESEARCH
SYNDICATED RESEARCH
MARKET INTELLIGENCE
SERVICES
CONSULT STUDIES
COUNTRY SPECIFIC
STUDIES
© Coherent market Insights. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS
SECTOR COVERAGE
Healthcare
CLINICAL DIAGNOSTIC
HEALTHCARE IT
MEDICAL IMAGING
PHARMACEUTICAL
MEDICAL DEVICES
Chemicals & Materials
Bulk Chemicals
Advanced
Materials
Speciality and Fine Chemicals
Green Chemicals
Food Ingredients
© Coherent market Insights. All Rights Reserved
Cosmetic Ingredients
Polymers & Resins
ABOUT COHERENT MARKET INSIGHTS
KEY STATS
RESEARCH SOLUTIONS
FEASIBILITY
STUDIES
GLOBAL
REPORTS
100+
Insights Published Per Year
150+
Consulting Projects Till Date
125+
Clients Worldwide Per Year
110+
COUNTRY
ANALYSIS
CONSULT
PROJECTS
SURVEY
RESEARC
H
EXCEL
FORECAST
DATABASE
CUSTOMIZED
SOLUTIONS
COMPETITIVE
ASSESSMENT
TECHNOLOGY
SNIPPETS
Analysts and Contract Consultants
Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and
food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across
various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our
clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained
growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein.
© Coherent market Insights. All Rights Reserved
To k no w mor e abo ut us , v is it o ur w eb site:
w ww.coh er en tmark etins ig hts.com
THANK YOU
© Coherent market Insights. All Rights Reserved
F or s ales q ueries o r new top ics email u s o n :
s ales@coh er en tmark etins ig hts .co m
Fo r o th er q uer ies co n tact:
Mr. Sh ah
( Man ag er - Bus iness D ev elo pment)
Co herent Mark et Ins ig hts
s ales@coh er en tmark etins ig hts .co m
+1 -2 06 -7 0 1- 67 02

The global medical cannabis market is valued at US$ 3,520.7 million in 2017 and is expected to witness a CAGR of 24.4% over the forecast period (2017 – 2025). Increasing approval of medicinal cannabis products and growing research and development activities in the medical cannabis market are expected to support the growth of the market.